Miriplatin
Alternative Names: DACHPM; Miripla; Miriplatin hydrate; SM 11355; SMP 11355Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Pharma
- Class Antineoplastics; Cyclohexanes; Platinum complexes
- Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Liver cancer